Verily Life Sciences and Samsung Electronics America today announced a collaboration that will bring together Samsung’s ...

Google's sibling company, Verily, will integrate data from Samsung’s Galaxy Watch, enabling research sponsors to run real-world studies.

Salesforce is building out its library of pre-wired artificial intelligence agents to take on manual, administrative work on ...

PALO ALTO, Calif., Feb. 25, 2026 /PRNewswire/ -- Segmed, Inc., a leader in real-world medical imaging and multimodal data for ...

At HIMSS26, Verily Life Sciences announced a partnership with Samsung Electronics to combine Galaxy Watch8 with Verily's precision health platform to further clinical research.

Every time Hugh publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...

Add Yahoo as a preferred source to see more of our stories on Google. Verily, the life sciences business under Alphabet, said Friday that it has raised $1 billion, capital that will be used to expand ...

Verily has rapidly ramped up its work in healthcare and research in the past two years with new initiatives and new hires. Leveraging its technology capabilities, Verily, a subsidiary of Alphabet and ...

Verily, Alphabet's life sciences unit, laid off staff this week. The layoffs hit a team working in molecular sciences. Are you a current or former Verily employee? Reach this reporter securely on ...

For Alphabet’s Verily, O is for OneOncology. The two companies have partnered up to accelerate cancer clinical trials. OneOncology, which brings together independent oncology practices, will integrate ...

It’s a make-or-break moment for Verily, as the sprawling Google offshoot rapidly accelerates its strategy to take its most promising products and turn them into tools that not only transform medicine, ...

After years spent building a seemingly slapdash set of medical initiatives, Verily seems to have a game plan. The Alphabet life sciences spinout is doubling down on the business of evidence generation ...